
Weekly Insulin Offers Simpler Diabetes Management for Some Patients
The story in brief
Once-weekly basal insulin represents a major advancement in type 2 diabetes treatment, offering simpler, more consistent management for patients struggling with daily injections. Experts emphasize that while weekly dosing may improve adherence and quality of life, daily insulin remains better for those with fluctuating needs. Awiqli, a weekly basal insulin injection, was recently launched in India.